콩 추출물을 함유하는 혈액 순환 개선 및 혈관 건강 증진용 조성물
    36.
    发明公开
    콩 추출물을 함유하는 혈액 순환 개선 및 혈관 건강 증진용 조성물 审中-实审
    包含用于改善血液循环和血管健康的豆提取物的组合物

    公开(公告)号:KR1020100127728A

    公开(公告)日:2010-12-06

    申请号:KR1020100049181

    申请日:2010-05-26

    Abstract: PURPOSE: A composition containing soybean extract isolated with low alcohol is provided to improve blood circulation and to treat obesity, diabetes, and hyperlipidemia. CONSTITUTION: A composition for improving blood circulation contains soybean extract isolating with 1-7% of C1-5 alcohol or fraction. The C1-5 alcohol is methanol, ethanol, isopropylalcohol, n-propylalcohol, n-butanol or isobutanol. The soybean extract or fraction contains adenosine. The fraction is an ethylacetate or butanol fraction. The composition suppresses thrombosis or cholesterol generation.

    Abstract translation: 目的:提供含有用低分子量分离的大豆提取物的组合物,以改善血液循环和治疗肥胖症,糖尿病和高脂血症。 构成:用于改善血液循环的组合物含有用1-7%的C1-5醇或级分分离的大豆提取物。 C 1-5醇是甲醇,乙醇,异丙醇,正丙醇,正丁醇或异丁醇。 大豆提取物或级分含有腺苷。 馏分是乙酸乙酯或丁醇馏分。 该组合物抑制血栓形成或胆固醇的产生。

    사포닌의 생체 이용률 증진 조성물
    37.
    发明公开
    사포닌의 생체 이용률 증진 조성물 有权
    用于改善SAPONIN生物利用度的组合物

    公开(公告)号:KR1020100127420A

    公开(公告)日:2010-12-06

    申请号:KR1020090045858

    申请日:2009-05-26

    CPC classification number: A61K36/79 A61K36/258 A61K36/896 A61K2300/00

    Abstract: PURPOSE: A ginseng complex composition which enhances the bioavailability of saponin is provided to improve the physiological activity of ginseng saponin. CONSTITUTION: A ginseng complex composition for enhancing the bioavailability of saponiin contains Schisandra chinensis extract or Liriope platyphylla extract and ginseng extract containing saponin. The ginseng extract is ginseng fruit extract. The saponin is ginsenoside Re. A composition for enhancing the bioavailability of saponin contains Schisandra chinensis extract or Liriope platyphylla extract as an active ingredient.

    Abstract translation: 目的:提高人参皂苷生理活性,提高皂角苷的生物利用度。 构成:提高saponiin生物利用度的人参复合物组合物含有五味子提取物或Liriope platyphylla提取物和含有皂苷的人参提取物。 人参提取物是人参水果提取物。 皂苷是人参皂甙Re。 用于提高皂角苷生物利用度的组合物含有五味子提取物或Liriope platyphylla提取物作为活性成分。

    2-사이클로펜텐-1-온 옥심 유도체를 유효성분으로 포함하는 지방대사질환 예방 및 치료용 약학 조성물
    39.
    发明公开
    2-사이클로펜텐-1-온 옥심 유도체를 유효성분으로 포함하는 지방대사질환 예방 및 치료용 약학 조성물 有权
    用于预防或治疗含有2-环戊烯-1-酮氧化衍生物的脂肪代谢相关疾病的药物组合物

    公开(公告)号:KR1020100103671A

    公开(公告)日:2010-09-27

    申请号:KR1020107017557

    申请日:2008-12-03

    CPC classification number: A61K31/15

    Abstract: PURPOSE: A pharmaceutical composition containing 2-cyclopentene-1-one oxime derivative is provided to promote adipose lysis in adipocytes(3T3-L1) and to prevent and treat lipid metabolic diseases including obesity and diabetes. CONSTITUTION: A pharmaceutical composition for preventing and treating lipid metabolic diseases contains 2-cyclopenten-1-one oxime derivative compound of chemical formula 1 or pharmaceutically acceptable salt thereof as an active ingredient. In chemical formula 1, R1 is linear or branched C1-C10 alkyl group or C3-C7 cycloalkyl group, or phenyl group with or without substituent. The phenyl group is denoted by chemical formula 2. The pharmaceutical composition is used for preventing and treating obesity, diabetes, or dyslipidemia.

    Abstract translation: 目的:提供含有2-环戊烯-1-酮肟衍生物的药物组合物,以促进脂肪细胞(3T3-L1)中的脂肪裂解,并预防和治疗脂肪代谢疾病,包括肥胖和糖尿病。 构成:用于预防和治疗脂质代谢疾病的药物组合物含有化学式1的2-环戊烯-1-酮肟衍生物化合物或其药学上可接受的盐作为活性成分。 在化学式1中,R 1为直链或支链C 1 -C 10烷基或C 3 -C 7环烷基,或具有或不具有取代基的苯基。 苯基由化学式2表示。药物组合物用于预防和治疗肥胖症,糖尿病或血脂异常。

    바닐로이드 수용체 길항제로 작용하는 신규 화합물, 이의 이성질체 또는 이의 약제학적으로 허용 가능한 염 및 이를 포함하는 약학 조성물
    40.
    发明公开
    바닐로이드 수용체 길항제로 작용하는 신규 화합물, 이의 이성질체 또는 이의 약제학적으로 허용 가능한 염 및 이를 포함하는 약학 조성물 有权
    新型化合物,异构体或其药学上可接受的盐作为VANULLOID受体拮抗剂和含有其的药物组合物

    公开(公告)号:KR1020100053470A

    公开(公告)日:2010-05-20

    申请号:KR1020090108632

    申请日:2009-11-11

    Abstract: PURPOSE: A novel compound which functions as a vanilloid receptor 1(VR1) antagonist is provided to prevent or treat disease related to hair growth, rhinitis, and pancreatitis. CONSTITUTION: A vanilloid receptor antagonist compound is denoted by chemical formula I. A pharmaceutical composition contains the compound, isomer, or pharmaceutically acceptable salt thereof. The composition is used for preventing or treating arthritis disease, neuropathy, HIV related neuropathy, nerve injury, neurodegeneration, cerebral apoplexy, urinary incontinence, cough, neuropathy/allergy/inflammation skin disease, atopic dermatitis, psoriasis, pruritus, the prurigo, acouesthesia, aliasing, bregma anaphylaxis, effluvium, or alopecia.

    Abstract translation: 目的:提供作为香草素受体1(VR1)拮抗剂起作用的新型化合物,以预防或治疗与毛发生长,鼻炎和胰腺炎有关的疾病。 构成:香草素受体拮抗剂化合物由化学式I表示。药物组合物含有化合物,异构体或其药学上可接受的盐。 该组合物用于预防或治疗关节炎疾病,神经病,HIV相关神经病,神经损伤,神经变性,脑中风,尿失禁,咳嗽,神经病变/过敏/炎症皮肤病,特应性皮炎,牛皮癣,瘙痒,瘙痒症,麻醉, 混叠,原发性过敏性反应,流出或脱发。

Patent Agency Ranking